Suspected fungal nail infection
Supports provider evaluation and treatment planning when clinically appropriate.
Onychomycosis Testing
Onychomycosis Testing with Pathology Stains and PCR
Ipsum Diagnostics offers onychomycosis testing that combines pathology stains and PCR technology to support accurate evaluation of suspected fungal nail infections.
Overview
Onychomycosis Testing overview
Provider-facing PCR testing support for clinically meaningful molecular diagnostic information.
This testing service supports evaluation of suspected fungal nail infection using both tissue-based pathology stains and molecular PCR methods.
It is designed for dermatology, podiatry, and other provider workflows where confirmation of fungal involvement can help guide treatment planning.
The combined approach may help providers better assess suspected fungal nail disease while avoiding unsupported assumptions from clinical appearance alone.
Clinical Use
When providers use this panel.
Thickened, discolored, or dystrophic nails
Supports provider evaluation and treatment planning when clinically appropriate.
Recurrent or persistent nail disease
Supports provider evaluation and treatment planning when clinically appropriate.
Need to distinguish fungal involvement from other nail disorders
Supports provider evaluation and treatment planning when clinically appropriate.
Treatment planning before antifungal therapy
Supports provider evaluation and treatment planning when clinically appropriate.
Dermatology or podiatry workflow support
Supports provider evaluation and treatment planning when clinically appropriate.
Molecular Testing Advantage
PCR-based detection designed to support clinical decision-making.
Combining pathology stains with PCR testing may provide both visual tissue-based evidence and molecular detection support, helping providers better evaluate suspected fungal nail disease.
Rapid pathogen detection
Molecular testing can help providers receive clinically useful information for interpretation alongside the full clinical picture.
Actionable information
Molecular testing can help providers receive clinically useful information for interpretation alongside the full clinical picture.
Provider-facing reporting
Molecular testing can help providers receive clinically useful information for interpretation alongside the full clinical picture.
Provider Workflow
A practical testing workflow for provider organizations.
Specimen Collection
Providers collect and submit specimens according to the final Ipsum Diagnostics ordering and collection instructions.
Laboratory Testing
The laboratory performs PCR-based molecular testing designed to detect relevant molecular targets for the submitted panel.
Results Reporting
Results are reported to support provider interpretation and timely clinical decision-making when clinically appropriate.
Provider Support
Ipsum Diagnostics can support onboarding, ordering questions, specimen guidance, and follow-up needs.
Partner With Ipsum Diagnostics
Partner with Ipsum Diagnostics
Contact Ipsum Diagnostics to learn more about this PCR testing panel, provider onboarding, specimen requirements, and ordering support.